The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs. [electronic resource]
Producer: 20000921Description: L496-502 p. digitalISSN:- 1040-0605
- Animals
- Blood Pressure -- drug effects
- Capillary Permeability -- drug effects
- Compliance
- Cyclic GMP -- metabolism
- Female
- In Vitro Techniques
- Ischemia -- metabolism
- Male
- Nitric Oxide -- physiology
- Organ Size -- drug effects
- Phosphodiesterase Inhibitors -- pharmacology
- Pulmonary Artery -- physiopathology
- Pulmonary Circulation -- drug effects
- Purinones -- pharmacology
- Rabbits
- Reperfusion Injury -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.